30.03.2012 - A U.S. court on Thursday ruled that the formulation patent for AstraZeneca's big-selling anti-psychotic drug Seroquel XR was valid and had been infringed by Mylan and other...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)